Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 14, 2023 01:00 ET | Source: Repairon gmbh

BioVAT-HF Phase 1/2 Reveals First Evidence for Effective Heart Repair in Advanced Heart Failure

Featured Late Breaking Clinical Science presentation at American Heart Association Scientific Sessions in PhiladelphiaSafe Maximal Dose Confirmed with 12-month follow-upProof for vascularized...
September 15, 2023 01:00 ET | Source: Repairon gmbh

Repairon Appoints Co-Founder Dr. Lothar Germeroth as Chief Executive Officer

GÖTTINGEN, Germany, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Repairon, a clinical-stage German biotech company focused on developing a novel reparative treatment for heart failure, today announced...
April 04, 2023 08:00 ET | Source: Repairon gmbh

Repairon Announces Completion of Dose-Finding Part of BioVAT-HF Phase 1/2 Trial in Advanced Heart Failure

Feasibility and safety demonstrated in patients with advanced heart failureSafe maximal dose for continuation into Phase 2 (Proof-of-Concept) identifiedProof for successful heart remuscularization...